Now Is A Suitable Moment For A Long-Term Purchase Of Arm Holdings plc. ADR (NASDAQ: ARM)

Currently, there are 1.06B common shares owned by the public and among those 1.05B shares have been available to trade.

The company’s stock has a 5-day price change of 3.46% and -19.69% over the past three months. ARM shares are trading 2.69% year to date (YTD), with the 12-month market performance up to 22.29% higher. It has a 12-month low price of $80.00 and touched a high of $188.75 over the same period. ARM has an average intraday trading volume of 5.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.99%, 13.05%, and -5.02% respectively.

Institutional ownership of Arm Holdings plc. ADR (NASDAQ: ARM) shares accounts for 6.68% of the company’s 1.06B shares outstanding.

It has a market capitalization of $133.90B and a beta (3y monthly) value of 4.24. The stock’s trailing 12-month PE ratio is 170.02, while the earnings-per-share (ttm) stands at $0.75. The company has a PEG of 7.60 and a Quick Ratio of 4.96 with the debt-to-equity ratio at 0.05. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.81% over the week and 4.14% over the month.

Earnings per share for the fiscal year are expected to increase by 11.02%, and 32.99% over the next financial year. EPS should grow at an annualized rate of 22.37% over the next five years, compared to 18.47% over the past 5-year period.

Looking at the support for the ARM, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on May 08, 2025, with the firm’s price target at $200-$155. UBS coverage for the Arm Holdings plc. ADR (ARM) stock in a research note released on November 25, 2024 offered a Buy rating with a price target of $160. Wells Fargo was of a view on November 22, 2024 that the stock is Overweight, while TD Cowen gave the stock Buy rating on November 07, 2024, issuing a price target of $150- $165. Bernstein on their part issued Underperform rating on October 31, 2024.

Most Popular

Related Posts